IPOs

Astounding success greets newly public device makers
EP Vantage
Mon, 01/18/21 - 12:59 pm
IPOs
devices
Medtech
Sotera Health
Outset Medical
Genetron Holdings
Burning Rock Biotech
Pulmonx
Acutus Medical
Nano-X Imaging
Eargo
Implantica
Inari Medical
Will Murky Trial Data Undercut Landos' $100 Million IPO Launch?
BioSpace
Thu, 01/14/21 - 10:30 pm
Landos Biopharma
IPOs
Emerging Seattle-Based Sana Biotechnology Seeks to Raise $150 Million IPO
BioSpace
Wed, 01/13/21 - 11:53 pm
IPOs
Sana Biotechnology
After a big year, biotech flotations have much to do
EP Vantage
Wed, 01/13/21 - 10:37 am
IPOs
biotech
2021 forecast: In spite of COVID-19—and partly because of it—biotech IPOs have a record year
Fierce Biotech
Tue, 12/22/20 - 11:27 pm
biotech
pandemic
IPOs
COVID-19
The biotech IPO train keeps chugging, as Virios prices $30M public debut
Endpoints
Thu, 12/17/20 - 11:55 am
Virios Therapeutics
IPOs
AbbVie's Covid-19 antibody partner wraps $221M Hong Kong IPO
Endpoints
Thu, 12/17/20 - 11:05 am
AbbVie
Harbour BioMed
IPOs
Hong Kong
BioAtla heads for Nasdaq on Wednesday following $189M IPO, going public with its pH-detecting cancer treatments
Endpoints
Wed, 12/16/20 - 11:32 am
BioAtla
IPOs
NASDAQ
TG Therapeutics set for upsized IPO to develop cancer combination drug
Pharmaforum
Tue, 12/15/20 - 10:33 am
TG Therapeutics
ASH2020
IPOs
CLL
AbCellera, tapped by Lilly for its COVID-19 antibody therapy, sets IPO terms with $5B valuation
Fierce Biotech
Mon, 12/7/20 - 10:37 am
AbCellera
Eli Lilly
R&D
Canada
COVID-19
antibodies
IPOs
Seer, a developer of protein analysis tools, prices upsized IPO at $19, above the range
Renaissance Capital
Fri, 12/4/20 - 10:56 am
R&D
IPOs
Seer
protein analysis
Sigilon Therapeutics prices upsized IPO at $18
Seeking Alpha
Fri, 12/4/20 - 10:54 am
IPOs
Sigilon
endocrine diseases
rare blood diseases
Kinnate Biopharma upsizes IPO and prices above range at $20 a share
Marketwatch
Fri, 12/4/20 - 10:53 am
Kinnate Biopharma
IPOs
NASDAQ
small molecule kinase inhibitors
Solid tumor biotech Silverback Therapeutics ups proposed deal size by 56% ahead of $195 million IPO
NASDAQ
Thu, 12/3/20 - 11:00 am
IPOs
Silverback Therapeutics
solid tumors
Overnight fortunes are being made in biotech these days — and it's both encouraging and more than a little bit scary
Endpoints
Tue, 11/24/20 - 10:43 am
Olema
IPOs
biotech
4DMT shoots for a $75M IPO, its second attempt to go public with its gene therapy vector programs
Endpoints
Wed, 11/18/20 - 12:12 pm
4D Molecular Therapeutics
IPOs
gene therapy
Seattle biotech firm Silverback Therapeutics aims for $100M IPO
Seattle Times, WA
Wed, 11/11/20 - 11:13 am
Silverback Therapeutics
IPOs
solid tumors
RemeGen grabs one of the world's largest ever biotech IPOs
Fierce Biotech
Mon, 11/9/20 - 11:10 am
RemeGen
IPOs
Hong Kong
JW Therapeutics hauls in $300M IPO just as liso-cel-inspired CAR-T nears the finish line in China
Endpoints
Wed, 11/4/20 - 10:30 am
JW Therapeutics
IPOs
CAR-T
liso-cel
China
Hong Kong
Juno Therapeutics
WuXi AppTec
Inhibikase Therapeutics slahes deal size ahead of IPO
Fierce Biotech
Wed, 11/4/20 - 10:27 am
Inhibikase Therapeutics
IPOs

Pages